TrialHeadache2010
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
David W Dodick et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
350 papers cite itlatest 60 shown
this paperpooled ittrialcites it